Navigation Links
Study focuses on mephedrone use in Northern Ireland post-ban

Researchers at Queen's University Belfast have completed one of the first studies of mephedrone use in Northern Ireland since the drug was outlawed earlier this year. They found that the ban did not deter those mephedrone users surveyed from taking the substance.

Interviews with 23 mephedrone users were completed during a two-month period (May and June 2010) following the legislation that made the drug illegal in the UK. Study participants were aged 19 to 51 years, around half of whom (12) were female. 19 of the 23 people who took part in the study were employed, and most occupations were affiliated with business, trades, the service industry or the public sector.

The research was led by Dr Karen McElrath at Queen's School of Sociology, Social Policy and Social Work.

The key findings from the study were:

  • 21 of the 23 study participants had used mephedrone after the ban.
  • Only one person was very much opposed to using the substance again.
  • Approximately half the sample preferred mephedrone to cocaine or ecstasy. Some had experienced negative effects, for example, sleeplessness, difficult comedowns and next-day depression, but these factors generally did not deter them from using the substance again.
  • None of those who took part in the research felt that 'legal highs' were safe simply because they were legal.
  • None of the study participants recalled an initial interest in using mephedrone because it had been legal. Rather, its legality before April 2010 meant that it was easier to access and cheaper than many illegal substances.
  • Prior to the ban, only three interviewees had purchased mephedrone from 'head shops' and four interviewees had purchased mephedrone from online suppliers. The majority tended to access mephedrone through friends or dealers.
  • The majority of interviewees had prior experience of taking ecstasy, amphetamine or cocaine.
  • During their most recent use of mephedrone, all the study participants had also consumed alcohol, although the timing and amount of alcohol varied.
  • During their most recent use of mephedrone, six of the 23 participants had used another psychoactive substance, other than alcohol.
  • During their most recent use of mephedrone, most participants had consumed between one-two grams of the drug, although half recalled bingeing on mephedrone, sharing upward of seven-eight grams with two to three other people.

Dr McElrath said: "This is one of the first studies into mephedrone use in Northern Ireland since it was made illegal earlier this year. The findings suggest that the ban did not have a significant impact on those who already used mephedrone, at least during the two-month period that followed the ban. We are keen to develop this research further and to compare our results with a similar study conducted in Waterford prior to the ban on mephedrone in the Republic of Ireland in May 2010."

The study was part of a cross-border research partnership with Marie Clare Van Hout at the Waterford Institute of Technology.


Contact: Anne-Marie Clarke
Queen's University Belfast

Related medicine news :

1. Despite Treatment, Employees with Depression Generate Higher Absentee Costs, According to Thomson Reuters Study
2. American Council on Exercise (ACE) Study Reveals Kettlebells Provide Powerful Workout in Short Amount of Time
3. TV drama can be more persuasive than news program, study finds
4. Study carried out into biological risks of eating reptiles
5. Neuroimaging study may pave way for effective Alzheimers treatments
6. Study finds racial gaps continue in heart disease awareness
7. Luth Researchs IndicatorEDG(TM) Study Finds Americans Hopes of Achieving Their Dreams Are Fading
8. First blinded study of venous insufficiency prevalence in MS shows promising results
9. Soothing infants with food focus of childhood obesity study
10. People with anxiety disorder less able to regulate response to negative emotions, study shows
11. American Heart Association Rapid Access Journal Report: Study Finds Racial Gaps Continue in Heart Disease Awareness, Low Knowledge of Heart Attack Warning Signs Among Women
Post Your Comments:
(Date:10/13/2017)... N.J. (PRWEB) , ... October 13, 2017 , ... The ... Holly Day Market. Featuring a collection of specialty vendors and unique items from across ... personalized and quality-focused health and wellness services offered by the VNA. The boutique ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... DIEGO , Oct. 12, 2017 AVACEN ... recognized the company with their  2017 New Product Innovation Award ... based on extensive primary and secondary medical device market research ... Medical, through its first-to-market OTC, drug-free pain relief product, the ... unique approach to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... Texas , Oct. 11, 2017  True ... services, has amplified its effort during National Breast ... about hereditary cancer risks. ... of Clinical Oncology calculated that more than 10 ... have inherited mutations in BRCA1 or BRCA2 and have ...
(Date:10/5/2017)... Ill. , Oct. 5, 2017  In ... Association of Oral and Maxillofacial Surgeons (AAOMS) released ... opioids – to be used as a first-line ... pain. Recognizing ... the AAOMS White Paper "Opioid Prescribing: Acute and ...
Breaking Medicine Technology: